Dermawound Wound Care Venous Stasis Ointment
NDC Package 57554-120-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dermawound Wound Care Venous Stasis (benzocaine hydrochloride) ointment is •Gently clean around the affected area•Prior to application of DermaWound®, evaluate the wound or ulcer to insure no excessive bleeding is present. This formulation utilizes a ointment delivery system. Marketed by Progressive Doctors, Llc, this product is identified by NDC 57554-120 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
57554-120-06
Package Description
1 TUBE in 1 CARTON / 179 g in 1 TUBE
Product Code
57554-120
11-Digit Billing Format
57554012006
RxNorm Crosswalk
  • RxCUI: 1552221 - benzocaine HCl 1.27 % Topical Ointment
  • RxCUI: 1552221 - benzocaine hydrochloride 0.0127 MG/MG Topical Ointment
  • RxCUI: 1552221 - benzocaine hydrochloride 1.27 % Topical Ointment
  • RxCUI: 1552226 - DermaWound Venous Stasis Formula 1.27 % Topical Ointment
  • RxCUI: 1552226 - benzocaine hydrochloride 0.0127 MG/MG Topical Ointment [Dermawound Benzocaine]

Clinical Specifications

Proprietary Name
Dermawound Wound Care Venous Stasis
Non-Proprietary Name
Benzocaine Hydrochloride
Substance Name
Benzocaine
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZOCAINE 1.27 g/100g
Pharmacologic Class
Usage Information
•Gently clean around the affected area•Prior to application of DermaWound®, evaluate the wound or ulcer to insure no excessive bleeding is present. Never wipe out the ulcer.•Apply a moderate amount of DermaWound® directly to affected area.•Deeper or "tunneling" wounds may require packing and/or sides coated with additional DermaWound® and sterile gauze.•Apply additional sterile gauze to absorb exudates, if needed.•Change Dressing 2 or 3 times daily or as directed by a physician.•May require supervision of a health care professional in the management of chronic & acute wound care, pressure sores, diabetic ulcers, surgical wounds & indwelling catheters.

Regulatory & Marketing

Labeler Name
Progressive Doctors, Llc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-01-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 57554-120-06 identifies a specific commercial package of 1 tube in 1 carton / 179 g in 1 tube of Dermawound Wound Care Venous Stasis, a human over the counter drug labeled by Progressive Doctors, Llc. This ointment is formulated for topical use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Progressive Doctors, Llc on February 01, 2014. The current certification is valid through December 31, 2026.

How is this Progressive Doctors, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 57554012006. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
57554-120-06
11-Digit CMS (5-4-2)
57554-0120-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.